Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Melanoma × Tranexamic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Hemorrhage 2 Recurrence 1 Postoperative Hemorrhage 1 Melanoma 1 Hematologic Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Blood Loss, Surgical 1

Interventions

Nivolumab 47 pembrolizumab 46 Ipilimumab 26 Cyclophosphamide 13 Specimen Handling 10 Radiosurgery 10 Magnetic Resonance Spectroscopy 10 Opdualag 9 fludarabine 8 Biopsy 8 relatlimab 7 binimetinib 7 Blood Specimen Collection 7 aldesleukin 6 Interleukin-2 6 encorafenib 5 cemiplimab 5 Paclitaxel 5 Bevacizumab 5 atezolizumab 4 Immunotherapy 4 CTLA-4 Antigen 4 trametinib 3 toripalimab 3 spartalizumab 3 dabrafenib 3 Temozolomide 3 Surgical Procedures, Operative 3 Standard of Care 3 Sodium Chloride 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05899465 2025-03-18

PRIME

University of Aarhus

Phase 3 Recruiting

Melanoma, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡